Stay updated on Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page’s footer now shows a newer site “Revision” version (v3.5.3 instead of v3.5.2), indicating a ClinicalTrials.gov site software update.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision: v3.5.2 was added and v3.5.0 was removed.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a site maintenance/version update with no visible changes to the study details.SummaryDifference0.0%

- Check53 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This appears to be a backend/UI version bump that does not modify the study content or how users interact with the page.SummaryDifference0.0%

- Check82 days agoChange DetectedFooter revision updated from v3.4.0 to v3.4.1, with no changes to study details or page navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic Thyroid Cancer Clinical Trial page.